Spectrum Pharma (SPPI) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts SPPI Hot Sheet
Price: $1.03 --0%
Financial Fact:
Income (loss) from operations: -16M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income (loss) from operations: -16M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Spectrum Pharma (NASDAQ: SPPI) reported Q3 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.56 million versus the consensus estimate of $24.93 million.
For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Datadog shares drop on weak Q4 revenue outlook
- Twin Disc (TWIN) Tops Q1 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
